Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477031
2.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296842
3.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843274
4.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605003
5.
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
EClinicalMedicine
; 69: 102485, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370537
6.
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.
Eur J Cancer
; 167: 70-80, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395553
7.
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
Cancers (Basel)
; 13(20)2021 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680228